Related Experiment Videos
Are Leydig cell steroidogenic enzymes differentially regulated with aging?
1Department of Population Dynamics, Johns Hopkins University, School of Hygiene and Public Health, Baltimore, Maryland 21205, USA.
Journal of Andrology
|September 1, 1996
Summary
Aging Leydig cells lose testosterone production due to reduced levels and activity of key steroidogenic enzymes, including P450 cholesterol side-chain cleavage (P450scc) and 17 alpha-hydroxylase (P450(17) alpha). This age-related decline impacts overall steroidogenesis.
Area of Science:
- Endocrinology
- Reproductive Biology
- Cellular Aging
Background:
- Leydig cell testosterone production declines with age in Brown Norway rats.
- Understanding the mechanisms behind age-related Leydig cell dysfunction is crucial for reproductive health.
Purpose of the Study:
- To investigate the impact of aging on the expression and activity of key steroidogenic enzymes in rat Leydig cells.
- To determine if age-related changes in mRNA, protein levels, or enzyme activity contribute to reduced testosterone production.
Main Methods:
- Northern blot analysis to assess mRNA levels of P450scc, 3 beta-HSD, and P450(17) alpha.
- Western blot analysis to quantify protein levels of P450scc, P450(17) alpha, and 3 beta-HSD.
- Enzyme activity assays to measure the function of P450scc, 3 beta-HSD, P450(17) alpha, and 17 beta-HSD.
Main Results:
- mRNA levels for P450scc and P450(17) alpha were reduced in aged rats, while 3 beta-HSD mRNA levels remained unchanged.
- Protein levels for all three enzymes (P450scc, P450(17) alpha, and 3 beta-HSD) were decreased in aged Leydig cells.
- Enzyme activities for P450scc, 3 beta-HSD, P450(17) alpha, and 17 beta-HSD were all significantly reduced with aging.
Conclusions:
- Age-related loss of steroidogenic function in Leydig cells is linked to reduced levels and activities of multiple steroidogenic enzymes.
- The decline in testosterone production is not due to the differential regulation of these specific enzymes but rather a general reduction across the pathway.